Isologic Innovative Radiopharmaceuticals Ltd.
Registration:
1
of
1
(2026-01-19
to
present)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Engage with government to expand British Columbians’ access to Positron Emission Tomography (PET) radiopharmaceuticals.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|